NCT07006155Recruiting
Biograph Vision 600 Versus Biograph Vision.X PET/CT
Summary
The main purpose is to evaluate initial clinical experiences and to explore whether the Vision.X system yields improved image quality and diagnostic performance compared to Vision 600.
Inclusion criteria
• Written Inform Consent to participating. • 18 to 85 years of age • Willing and able to comply with the requirements of the study, as judged by the investigator
Exclusion criteria
• Women in pregnancy • Patients unable to lie still for the duration of the examination
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- No phase (N/A)
- Study type
- Interventional
- Countries
- Switzerland
- Sponsor
- Valentina Garibotto(Other)
- Protocol no.
- 2025-D00005
- Conditions
- Cancer, Alzheimer Disease
- Interventions
- Device
Treatments studied
- Images
Locations · 1
- Geneva, SwitzerlandHopitaux Universitaires de GenèveRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: June 5, 2025).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.